Artículo
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients
Neukam, Karin; Almeida, Carmen; Caruz, Antonio; Rivero Juarez, Antonio; Rallon, Norma; Di Lello, Federico Alejandro
; Herrero, Rocío; Camacho, Angela; Benito, José; Macias, Juan; Rivero, Antonio; Soriano, Vicente; Pineda, Juan Antonio
Fecha de publicación:
12/12/2012
Editorial:
Oxford University Press
Revista:
Journal of Antimicrobial Chemotherapy
ISSN:
0305-7453
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Accurate prediction of sustained virological response (SVR) to pegylated interferon-a (Peg-IFN) plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients could improve the management of these patients. We aimed to develop a model to predict SVR to Peg-IFN/ribavirin in HIV/HCV-coinfected individuals combining HCV genotype and baseline HCV RNA load with interleukin 28B and low-density lipoprotein receptor genetic variations.
Palabras clave:
HCV GENOTYPE
,
HCV VIRAL LOAD
,
INTERFERON-Α
,
INTERLEUKIN 28B
,
RIBAVIRIN
,
VIRUSES
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(OCA HOUSSAY)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY
Citación
Neukam, Karin; Almeida, Carmen; Caruz, Antonio; Rivero Juarez, Antonio; Rallon, Norma; et al.; A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients; Oxford University Press; Journal of Antimicrobial Chemotherapy; 68; 4; 12-12-2012; 915-921
Compartir
Altmétricas